| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/23/2001 | WO2001060852A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF |
| 08/23/2001 | WO2001060851A1 Staphylococcal enterotoxin sec-ser, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
| 08/23/2001 | WO2001060849A2 Cold-adapted equine influenza viruses |
| 08/23/2001 | WO2001060847A2 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060404A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 08/23/2001 | WO2001060403A1 Gm-negative ehv-mutants |
| 08/23/2001 | WO2001060402A2 Proteosome influenza vaccine |
| 08/23/2001 | WO2001060400A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060391A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | WO2001060317A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 08/23/2001 | WO2001025793A3 Diagnosis of coeliac disease using a gliadin epitope |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |
| 08/23/2001 | WO2001009298A3 Strategy for carbohydrate-based cancer vaccines |
| 08/23/2001 | WO2001009290A3 Avian infectious bronchitis virus serotype |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001007479A3 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000074634A3 Methods and compositions for modulating cell proliferation and cell death |
| 08/23/2001 | WO2000061737A3 Production of attenuated negative stranded RNA virus vaccines |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016645 Vitazin antibody; treating angiogenesis or restenosis |
| 08/23/2001 | US20010016644 Protein of given molecular weight and given N-terminal amino acid sequence |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016200 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 08/23/2001 | US20010016198 T cell receptor ligands and methods of using same |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | US20010015159 Ultra fine fly ash and a system for collecting the same |
| 08/23/2001 | DE10007771A1 Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung Immunomodulatory effective compositions, processes for their preparation and their use |
| 08/23/2001 | DE10006033A1 New pharmaceutical for immunization against a carcinoma and its preliminary stages contains a cell cycle regulatory protein, particularly the cyclin-dependent kinase inhibitor p16 |
| 08/23/2001 | DE10002820A1 Aminopeptidasen-Inhibitor Aminopeptidase inhibitor |
| 08/23/2001 | CA2402440A1 Aids ancestral viruses and vaccines |
| 08/23/2001 | CA2400495A1 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2399816A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | CA2398872A1 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126023A1 Method for inducing cellular immunity and cells with induced cellular immunity |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125585A1 Remedies for immunological diseases |
| 08/22/2001 | EP1125583A1 Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers |
| 08/22/2001 | EP1124989A1 Method for determining cancer by determining expression of mage-10 |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124856A1 Conformation-specific anti-von willebrand factor antibodies |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124579A1 Composite product and method and apparatus for its formation |
| 08/22/2001 | EP1124578A1 Novel immunoadjuvants |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124576A2 Method for preparing solid phase conjugate vaccines |
| 08/22/2001 | EP1124575A1 Method for the production of an antiviral agent |
| 08/22/2001 | EP1124574A2 Component for vaccine against serogroup b meningococci |
| 08/22/2001 | EP1124569A2 Composition and method for increasing weight gain and feed efficiency |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0697880B1 Inhibition of leukocyte adhesion |
| 08/22/2001 | EP0696208B1 Oral drug delivery compositions |
| 08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
| 08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309664A Anti hepatitis C virus antibody and uses thereof |
| 08/22/2001 | CN1309662A Chemotaxis-inhibiting protein of i(staphylococcus) (CHIPS) and its use |
| 08/22/2001 | CN1309569A Composition comprising tumor cells and extracts and method for using thereof |
| 08/22/2001 | CN1309555A Incorporation of active substances in carrier matrixes |
| 08/22/2001 | CN1308967A Method for producing transgenic plant to express protein in hepatitis B virus envelope and its products |
| 08/22/2001 | CN1308966A Antitumor cell-protein preparation |
| 08/22/2001 | CN1308937A Method for preparing microcapsule |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277973 Dna which codes for epitopes of protein of defined amino acid sequence; antigens for vaccines and treatment of infections in animals; primers and probes for detection and diagnosis |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277971 Dna which codes for nap protein of defined amino acid sequence; diagnosis and treatment of acquired immune deficiency syndrome (aids) |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |